Where can I find more data?

The fourth component is a group of nine housekeeping genes whose measurement allows normalization of the RNA expression for analysis.

It's melanoma.
‍Now what?

You deserve answers, not hat?

Know your risk and navigate your melanoma journey with confidence. We will connect you a doctor

When you’ve been diagnosed with melanoma, uncertainty is common. DecisionDx-Melanoma provides genomic insights that help your care team better understand your risk. Decisions feel clearer and more confident.

Download your starter kit

Why tumor biology matters: Leah and Dr. Trotter on personalized melanoma care

Your tumor biology matters

DecisionDx-Melanoma is a gene expression profile (GEP) test that examines the activity of 31 genes in your tumor to predict how your melanoma may behave — including likelihood of spreading or returning. Uses a small sample from the original biopsy. Available for Stage I–III cutaneous melanoma.

Represents the only melanoma genomic test shown to be associated with improved patient survival¹

Uses your tumor biology to deliver personalized insights to help guide more precise care

Offers coverage through Medicare and many private insurers, with an market-leading financial assistance program.

I want to connect to a provider near me

Frequently asked questions

What does this mean for my treatment?

By better understanding the risk of your individual tumor biology, your provider can make better management decisions. The bottom line? More personalized treatment leads to better outcomes.

Are all GEP tests the same?

Not all GEP tests are the same. DecisionDx-Melanoma is the only test that can provide you with a comprehensive test result that gives you a clinically validated, personalized risk assessment. DecisionDx-Melanoma is the only test with over 200,000 patients studied and 50 peer-reviewed publications

The value of a test is driven by the value of information it provides. DecisionDx-Melanoma has continued to show that it offers data that is above and beyond what traditional staging can provide.

		Other GEP tests
Identifies patient risk for nodal metastasis	✔	✔
Provides personalized risk for sentinel lymph node positivity	✔	x
Provides personalized risk of recurrence including MSS, RFS, and DMFS	✔	x
Data demonstrates independent, significant risk stratification provided by GEP result compared to AJCC stage	✔	x
Data demonstrates improved patient survival associated with testing	✔	x

Where can I find more information?

Click here to learn more about melanoma.

Click here for Scientific Evidence on DecisionDx-Melanoma.

Patients and providers agree: DecisionDx-Melanoma provides essential insights

of patients found their DecisionDx-Melanoma test results useful.

of patients reported wanting DecisionDx-Melanoma test results when first diagnosed.

of providers believe DecisionDx-Melanoma enhances patient care and decision-making.

Take the next step - your voice matters in your care

Wherever you are in your melanoma journey, you deserve clarity. Ask your doctor about DecisionDx-Melanoma and take the next step toward informed, confident care.

Get connected to a provider

We can help you find a provider near you who offers the DecisionDx-Melanoma test. Fill out the form below and we will be in touch with more information.

I want to get connected to a provider

Discuss the test with your current provider

Feel confident initiating a conversation about adding this test to your treatment plan. Since only a doctor can order DecisionDx-Melanoma, taking that first step is important. Use the guide below to help you ask with confidence.

I want to download the discussion guide